Role of Macrophage Migration Inhibitory Factor (MIF) in Heart Failure
NCT03232671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2022-11-04
Summary
Evaluating the additional value of Macrophage Migration Inhibitory factor (MIF) in cardiovascular diseases when assessed in clinical routine.
Conditions
- Heart Diseases
Interventions
- DIAGNOSTIC_TEST
-
MIF ELISA
Blood sample
Sponsors & Collaborators
-
University Hospital, Essen
lead OTHER
Principal Investigators
-
Peter Lüdike, M.D. · University Hospital of Essen, Department of Cardiology and Vascular medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2020-04-30
- Completion
- 2020-09-01
Countries
- Germany
Study Locations
More Related Trials
-
CMR Exercise Stress Testing in HFpEF
NCT03260621 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Evaluation of Myocardial Stiffness by Elastography
NCT02537041 ·Status: COMPLETED ·Phase: NA
-
MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension
NCT02858791 ·Status: COMPLETED
-
Cardiogenic Shock Integrated PHenotyping for Event Reduction
NCT04323371 ·Status: RECRUITING
-
Peripheral Microvascular Blood Flow in ANOCA
NCT05610410 ·Status: COMPLETED
-
Metabolomics and Microbiomics in Cardiovascular Diseases
NCT04146701 ·Status: UNKNOWN
-
Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.
NCT02014701 ·Status: UNKNOWN ·Phase: NA
-
Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction
NCT00576121 ·Status: WITHDRAWN
-
Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF
NCT06208007 ·Status: RECRUITING
-
The Relationship Between FAPI Results and Myocardial Fibrosis After Acute Myocardial Infarction
NCT06841549 ·Status: COMPLETED
-
Impact of Iron Deficiency and Its Correction on Mitochondrial Metabolism of the Cardiomyocyte (MitoCardioFer)
NCT03541213 ·Status: COMPLETED ·Phase: NA
-
Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection
NCT04327479 ·Status: COMPLETED
-
Impact of Peripheral Vascular Stiffness Assessment on Risk Prediction in Patients With Myocardial Infarction
NCT04058782 ·Status: ACTIVE_NOT_RECRUITING
-
Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure
NCT05573997 ·Status: RECRUITING
-
Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction
NCT00738517 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Changes in Myocardial Iron After Iron Administration
NCT03398681 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostics for the Reperfusion Injury Following MI
NCT00529607 ·Status: COMPLETED
-
Myocardial Oedema in Acute Myocardial Infarction (AMI)
NCT00987259 ·Status: COMPLETED
-
Left Ventricular Function After Primary Percutaneous Coronary Intervention: Role of Speckle Echocardiography
NCT04103008 ·Status: UNKNOWN
-
Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction
NCT02649517 ·Status: UNKNOWN ·Phase: NA
-
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
NCT06030596 ·Status: UNKNOWN
-
xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease
NCT04583787 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness
NCT03430583 ·Status: COMPLETED ·Phase: PHASE3
-
Ceramide Level as Apredictor of Outcomes in Patients of Anterior Myocardial Infarction Undergoing Primary Coronary Intervention
NCT04572191 ·Status: UNKNOWN
-
The Arrhythmogenic Potential of Midwall Septal Fibrosis in Dilated Cardiomyopathy
NCT05026112 ·Status: UNKNOWN